Patusky Christopher's Form 4 filing
United Therapeutics Corp (UTHR) · filed May 3, 2023
- Accession no.
- 0001104659-23-055524
- Filed
- May 3, 2023
- Trade date
- Jul 17, 2017-Jun 10, 2019
- Filing delay
- 2,116 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 9 non-derivative transactions. Open-market purchases total $2.42K. Open-market sales total $1.89K. It was filed 2116 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Patusky ChristopherCIK 0001231427 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 17, 2017 | Common Stock | PPurchaseAcquired | +3 | $130.24 | +$390.72 | 1,683 | Direct | |
| Jul 28, 2017 | Common Stock | PPurchaseAcquired | +3 | $128.35 | +$385.05 | 1,686 | Direct | |
| Oct 20, 2017 | Common Stock | SSaleDisposed | −6 | $121.01 | −$726.06 | 1,680 | Direct | |
| Nov 20, 2017 | Common Stock | PPurchaseAcquired | +5 | $126.20 | +$631 | 1,685 | Direct | |
| Mar 20, 2018 | Common Stock | SSaleDisposed | −5 | $107.71 | −$538.55 | 1,680 | Direct | |
| Apr 20, 2018 | Common Stock | PPurchaseAcquired | +6 | $114.06 | +$684.36 | 1,686 | Direct | |
| May 21, 2018 | Common Stock | SSaleDisposed | −2 | $104.12 | −$208.24 | 1,684 | Direct | |
| Dec 28, 2018 | Common Stock | SSaleDisposed | −4 | $105.11 | −$420.44 | 1,680 | Direct | |
| Jun 10, 2019 | Common Stock | PPurchaseAcquired | +4 | $82.83 | +$331.32 | 1,684 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.
Remarks
The transactions reported in this Form 4 were executed by the reporting person's investment advisor in a managed account as part of the investment advisor's implementation of a large-cap investment strategy involving the securities of multiple issuers. The reporting person was unaware of the transactions at the time they occurred. Short swing profits resulting from these transactions have been returned to the Issuer.